RedHill Biopharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for RedHill Biopharma Ltd. (RDHL) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.000.010.020.030.000.010.05
Short-Term Investments0.000.000.000.010.000.000.00
Cash & Short-Term Investments0.000.010.020.040.000.010.05
Accounts Receivable0.000.000.040.030.030.000.00
Inventory0.000.000.010.010.010.000.00
Other Current Assets0.000.000.000.000.010.000.00
Total Current Assets0.010.020.090.090.040.020.06
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.010.000.010.000.00
Long-Term Investments0.000.000.000.000.000.000.00
Intangible Assets0.010.010.070.070.090.000.00
Other Non-Current Assets0.000.000.000.020.020.000.00
Total Non-Current Assets0.010.010.070.090.110.020.01
Total Assets0.020.020.160.180.150.040.06
Current Liabilities
Accounts Payable0.010.000.000.010.050.010.01
Short-Term Debt0.000.000.120.000.000.000.00
Current Portion of Long-Term Debt0.000.000.120.000.000.000.00
Accrued Liabilities0.000.000.060.020.040.000.00
Other Current Liabilities0.000.000.010.000.000.010.00
Total Current Liabilities0.020.020.200.080.070.020.01
Non-Current Liabilities
Long-Term Debt0.000.000.010.080.090.000.00
Other Non-Current Liabilities0.000.000.000.000.010.000.00
Total Non-Current Liabilities0.000.000.010.090.090.000.00
Total Liabilities0.020.020.210.170.170.020.01
Stockholders' Equity
Common Stock0.040.020.000.000.000.000.00
Retained Earnings-0.41-0.41-0.43-0.37-0.28-0.21-0.17
Additional Paid-in Capital0.380.390.380.380.290.270.22
Shares Outstanding12.907.870.930.520.000.000.00
Total Stockholders' Equity0.000.00-0.050.010.010.060.05
Total Liabilities & Equity0.020.020.160.180.150.040.06